Diabetes, Vol 47, Issue 9 1464-1471, Copyright © 1998 by American Diabetes Association

ARTICLES

Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements

M Ito, D Grujic, ED Abel, A Vidal-Puig, VS Susulic, J Lawitts, ME Harper, J Himms-Hagen, AD Strosberg and BB Lowell
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.

Beta-adrenergic receptors (ARs) are expressed predominantly in adipose tissue, and beta3-selective agonists are effective anti-obesity drugs in rodents. Rodent and human beta3-ARs differ with respect to expression in white versus brown adipocytes as well as their ability to be stimulated by beta3-AR-selective agonists. Humans express beta3-AR mRNA abundantly in brown but not white adipocytes, while rodents express beta3-AR mRNA abundantly in both sites. To determine the basis for this difference, we have transgenically introduced 74 kilobases (kb) of human beta3-AR genomic sequence into gene knockout mice lacking beta3-ARs. Importantly, human beta3-AR mRNA was expressed only in brown adipose tissue (BAT) of transgenic mice, with little or no expression being detected in white adipose tissue (WAT), liver, stomach, small intestine, skeletal muscle, and heart. This pattern of expression differed from that observed in mice bearing a murine beta3-AR genomic transgene in which beta3-AR mRNA was expressed in both WAT and BAT, but not in other sites. Furthermore, we have transgenically introduced smaller human constructs containing -14.5 and -0.6 kb of upstream sequence into beta3-AR gene knockout mice. Both -14.5 and -0.6 kb constructs were expressed in BAT but not WAT. Thus, human but not murine cis-regulatory elements direct beta3-AR gene expression preferentially to brown adipocytes. Identification of responsible cis-regulatory element(s) and relevant trans-acting factor(s) should provide insight into mechanisms controlling human beta3-AR gene expression. In addition, the beta3-AR agonist, CGP-12177, stimulated oxygen consumption in mice expressing human but not murine beta3-ARs by 91% compared with only 49% in control beta3-AR gene knockout mice, demonstrating that the human beta3-AR can functionally couple with energy expenditure. These "humanized" mice should assist us in the development of drugs that may become effective anti-obesity agents in humans.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Tavernier, M. Jimenez, J.-P. Giacobino, N. Hulo, M. Lafontan, P. Muzzin, and D. Langin Norepinephrine Induces Lipolysis in {beta}1/{beta}2/{beta}3-Adrenoceptor Knockout Mice Mol. Pharmacol., September 1, 2005; 68(3): 793 - 799. [Abstract] [Full Text] [PDF]

				J. G. Granneman, M. Burnazi, Z. Zhu, and L. A. Schwamb White adipose tissue contributes to UCP1-independent thermogenesis Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1230 - E1236. [Abstract] [Full Text] [PDF]

				B. B. Lowell and E. S. Bachman {beta}-Adrenergic Receptors, Diet-induced Thermogenesis, and Obesity J. Biol. Chem., August 8, 2003; 278(32): 29385 - 29388. [Full Text] [PDF]

				P. Jost, M. Fasshauer, C. R. Kahn, M. Benito, M. Meyer, V. Ott, B. B. Lowell, H. H. Klein, and J. Klein Atypical beta -adrenergic effects on insulin signaling and action in beta 3-adrenoceptor-deficient brown adipocytes Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E146 - E153. [Abstract] [Full Text] [PDF]

				P. Valet, G. Tavernier, I. Castan-Laurell, J. S. Saulnier-Blache, and D. Langin Understanding adipose tissue development from transgenic animal models J. Lipid Res., June 1, 2002; 43(6): 835 - 860. [Abstract] [Full Text] [PDF]

				V. S. Susulic, L. LaVallette, E. Duzic, L. Chen, D. Shuey, S. K. Karathanasis, and K. E. Steiner Expression of the Human {beta}3-Adrenergic Receptor Gene in SK-N-MC Cells Is Under the Control of a Distal Enhancer Endocrinology, May 1, 2001; 142(5): 1935 - 1949. [Abstract] [Full Text]

				J. G. Granneman The putative {beta}4-adrenergic receptor is a novel state of the {beta}1-adrenergic receptor Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E199 - E202. [Abstract] [Full Text] [PDF]

				A. Inui Transgenic Approach to the Study of Body Weight Regulation Pharmacol. Rev., March 1, 2000; 52(1): 35 - 62. [Abstract] [Full Text] [PDF]

				A. A. Konkar, Y. Zhai, and J. G. Granneman beta 1-Adrenergic Receptors Mediate beta 3-Adrenergic-Independent Effects of CGP 12177 in Brown Adipose Tissue Mol. Pharmacol., February 1, 2000; 57(2): 252 - 258. [Abstract] [Full Text]